Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU chemicals regulation nears final stages

This article was originally published in Clinica

Executive Summary

The European Parliament's environment and public health committee was due to vote on the draft EU chemicals regulation, REACH, on October 4. This is the last of ten EP committees to give its opinion on the text; over 1,000 amendments by five committees were adopted in mid-September. The aim of the text is to prevent exposure to unsafe chemicals, but the European Commission has also stressed the need to safeguard the competitiveness of Europe's industry - and SMEs in particular. The final text may impact the medical device and diagnostics industry's access to materials used in the manufacture and sterilisation of its products. Rapporteur Guido Sacconi now faces the task of having to bring all the amendments together. He fears that so many changes may water down REACH's initial aims of replacing hazardous products, placing a burden of proof on industry and not overloading the future European Agency for Chemical Products. The text will begin to be debated at the Council from this week.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT056544

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel